RA CAPITAL MANAGEMENT, L.P.

Q4 2021 13F-HR Holdings

Location
Boston, MA
Holdings as of
12/31/2021
Date filed
2/14/2022
Form type
13F-HR
Num holdings
97
Total value ($000)
$5,671,942
Net value change ($000)
-1,544,802 (-21.4%)
New positions
11
Sold out positions
9
Turnover %
11.2%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/15/2021 Next filing: 5/16/2022 SEC filing

Snapshot: Change Analysis

Compared to Q3 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
iTeos Therapeutics, Inc. 86,402 72.4%
BELLUS Health Inc. 82,354 NEW
Mirati Therapeutics, Inc. 55,896 NEW
PARDES BIOSCIENCES, INC. 51,190 NEW
LIANY 47,155 NEW
ImmunoGen, Inc. 45,765 43.8%
RLMD 45,060 NEW
TVTX 38,122 28.0%
XLO 32,035 NEW
PYXS 25,035 NEW
Top Reduces (Value $000, Stocks/ETFs)
AVIR -190,294 -100.0%
IVVD -189,297 -83.9%
ASND -159,447 -13.5%
NVAX -134,763 -31.0%
CNTB -133,388 -78.7%
CLYM -98,894 -41.8%
TGTX -94,399 -69.2%
Forma Therapeutics Holdings, Inc. -80,834 -38.7%
ABOS -79,144 -54.5%
JBIO -75,946 -43.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type